AQR Capital Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Buy |
383,789
+243,257
| +173% | +$348K | ﹤0.01% | 2570 |
|
|
2025
Q1 | $225K | Buy |
140,532
+127,244
| +958% | +$204K | ﹤0.01% | 2830 |
|
|
2024
Q4 | $47.8K | Sell |
13,288
-25,668
| -66% | -$92.4K | ﹤0.01% | 2810 |
|
|
2024
Q3 | $222K | Buy |
+38,956
| New | +$222K | ﹤0.01% | 2521 |
|
|
2024
Q1 | – | Sell |
-148,610
| Closed | -$840K | – | 2426 |
|
|
2023
Q4 | $840K | Sell |
148,610
-944,489
| -86% | -$5.34M | ﹤0.01% | 1665 |
|
|
2023
Q3 | $2.03M | Buy |
1,093,099
+540,895
| +98% | +$1.01M | ﹤0.01% | 1317 |
|
|
2023
Q2 | $1.52M | Sell |
552,204
-54,261
| -9% | -$149K | ﹤0.01% | 1383 |
|
|
2023
Q1 | $1.9M | Buy |
606,465
+331,373
| +120% | +$1.04M | ﹤0.01% | 1277 |
|
|
2022
Q4 | $1.62M | Buy |
275,092
+182,924
| +198% | +$1.08M | ﹤0.01% | 1347 |
|
|
2022
Q3 | $808K | Buy |
92,168
+17,439
| +23% | +$153K | ﹤0.01% | 1596 |
|
|
2022
Q2 | $563K | Buy |
+74,729
| New | +$563K | ﹤0.01% | 1643 |
|